-
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibition
Niccolai, R., Göbel, C., Ndoj, K., Kreft, M., Kuiken, H. J., Lieftink, C., Morris, B., Yska, S. D., Hendrix, S., van den Broek, B., Pappalardo, V., Kersten, M. J., Beijersbergen, R. L., Zelcer, N., van Leeuwen, F. & Jacobs, H., 1 Dec 2025, In: Neoplasia (United States). 70, 101243.Research output: Contribution to journal › Article › Academic › peer-review
-
The low-density lipoprotein receptor: Emerging post-transcriptional regulatory mechanisms
Ndoj, K., Meurs, A., Papaioannou, D., Bjune, K. & Zelcer, N., 1 Feb 2025, In: Atherosclerosis. 401, 119082.Research output: Contribution to journal › Review article › Academic › peer-review
-
A suite of genome-engineered hepatic cells provides novel insights into the spatiotemporal metabolism of apolipoprotein B and apolipoprotein B-containing lipoprotein secretion
Meurs, A., Ndoj, K., van den Berg, M., Marinković, G., Tantucci, M., Veenendaal, T., Kuivenhoven, J. A., Klumperman, J. & Zelcer, N., 1 Jul 2024, In: Cardiovascular Research. 120, 11, p. 1253-1264 12 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications